Cardiovascular Risk Evaluation and Antiretrovirals in HIV

Completed

• Conditions: Cardiovascular Risk; HIV Infections

• Registration Number: NCT01015092
• Lead Sponsor: King's College London

Brief Summary

The purpose of the study is to determine the main factors contributing to predicted 10 year cardiovascular risk in an HIV infected cohort, and the role of anti-HIV drug use in altering this risk

Detailed Description

Not available

Study Timeline

• Study Start: 2005-06
• Primary Completion: 2006-09
• Study Completion: 2006-11
• Status Verified: 2009-11
• Study First Submitted: 2009-11-16
• Study First Submitted QC: 2009-11-16
• Last Update Submitted: 2009-11-16
• Study First Posted: 2009-11-17
• Last Update Posted: 2009-11-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1024

Inclusion Criteria

• Serologically proven HIV infection
• Attending general HIV outpatient clinic

Exclusion Criteria

• Attending a specialist outpatient clinic which might lead to recruitment bias

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
10 year predicted cardiovascular risk	AT time of clinic attendence

Secondary Outcome Measures

Name	Time	Method
coronary heart disease risk	at time of clinic attendence

Trial Locations

Locations (1)

Guys & ST Thomas' Foundation Hospitals; 🇬🇧 London, United Kingdom